| Literature DB >> 29386415 |
M G Deo1, P V Pawar1, S R Kanetkar2, S V Kakade2.
Abstract
BACKGROUND AND OBJECTIVES: Although a number of studies have been conducted on the prevalence of hypertension (HTN) and diabetes on tribal populations in different parts of India, comparative tribe-specific information is very meager. The main objective of this study is to generate tribe-specific information on the noncommunicable disorders (NCDs) and associated risk factors in scheduled tribes (STs) in Coastal and Western Maharashtra.Entities:
Mesh:
Year: 2018 PMID: 29386415 PMCID: PMC5820811 DOI: 10.4103/jpgm.JPGM_245_17
Source DB: PubMed Journal: J Postgrad Med ISSN: 0022-3859 Impact factor: 1.476
Figure 1Study areas and concerned tribes
Sociocultural profile of the study population as per the 2011 Census
| STs | Number of households | ST rank in the state | Population | Population (aged 0-6 years) | Total (%) | ||||
|---|---|---|---|---|---|---|---|---|---|
| Total | Female:male | Total (%) | Female:male | Literate | Workers | Cultivators | |||
| All STs | 2,273,907 | 10,510,213 | 0.98 | 1,553,366 (14.80) | 0.96 | 5,887,161 (56.00) | 5,323,325 (50.64) | 1,156,385 (21.72) | |
| Bhils | 512,708 | 1 | 2,588,659 | 0.98 | 460,973 (17.88) | 0.96 | 1,120,155 (43.27) | 1,349,147 (52.11) | 195,990 (14.53) |
| Kokana | 143,647 | 5 | 687,431 | 0.98 | 91,742 (13.34) | 0.97 | 420,160 (61.12) | 363,323 (52.85) | 194,071 (53.42) |
| Thakurs | 115,877 | 6 | 567,968 | 0.97 | 87,323 (15.37) | 0.95 | 300,263 (52.86) | 278,952 (49.11) | 65,415 (23.45) |
| Katkaris | 67,392 | 8 | 285,334 | 1.00 | 52,105 (18.25) | 0.96 | 97,204 (34.06) | 147,347 (51.64) | 5,466 (3.71) |
STs: Scheduled tribes, BH: Bhils, KO: Kokana, KA: Katkaris, TH: Thakar
Age and gender distribution of the study population in comparison with the 2011 Census
| Tribes | Gender | Total participant | Mean age (years)±SD | Age (years) group distribution and percentage (number of participants shown in parentheses) | ||
|---|---|---|---|---|---|---|
| 18-39 | 40-59 | ≥60 | ||||
| BH | Females | 360 | 40.3±16.36 | 58.6 (211) | 23.6 (85) | 17.8 (64) |
| Males | 388 | 38.3±16.40 | 62.6 (243) | 22.7 (88) | 14.7 (57) | |
| KA | Females | 297 | 34.5±13.56 | 69.7 (207) | 20.5 (61) | 9.8 (29) |
| Males | 263 | 34.4±12.83 | 68.4 (180) | 24.3 (64) | 7.3 (19) | |
| KO | Females | 191 | 37.5±14.43 | 59.7 (114) | 27.7 (53) | 12.6 (24) |
| Males | 161 | 38.2±14.67 | 56.5 (91) | 29.2 (47) | 14.3 (23) | |
| TH | Females | 112 | 35.9±13.04 | 58.9 (66) | 34.8 (39) | 6.3 (7) |
| Males | 92 | 38.1±14.80 | 59.8 (55) | 28.3 (26) | 11.9 (11) | |
| All tribes | Females | 960 | 37.2±14.89 | 62.3 (598) | 24.8 (238) | 12.9 (124) |
| Males | 904 | 37.1±15.04 | 62.6 (569) | 24.9 (225) | 12.2 (110) | |
| 2011 Census | Females | 62.8 | 25.8 | 11.4 | ||
| Males | 63 | 27 | 10 | |||
BH: Bhils, KO:Kokana, KA:Katkaris, TH:Thakar, SD: Standard deviation
Socioeconomic, educational, and dietary pattern in the study population
| Women (219) | Women (718) | Men (191) | Men (694) | |||
|---|---|---|---|---|---|---|
| Income | ||||||
| Below BPL (yellow card)* | 212 (96.8) | 572 (79.7) | 34.83 (<0.0001) | 183 (95.8) | 546 (78.7) | 27.88 (<0.0001) |
| Above BPL | 7 (3.2) | 132 (18.4) | 8 (4.2) | 132 (19.0) | ||
| Middle income | 14 (1.9) | 16 (2.3) | ||||
| Occupation | ||||||
| Manual labor | 219 (100.0) | 246 (34.3) | 258.55 (<0.0001) | 191 (100.0) | 258 (37.2) | 234.01 (<0.0001) |
| Farmer | 470 (65.5) | 432 (62.2) | ||||
| Salaried | 2 (0.3) | 4 (0.6) | ||||
| Education | ||||||
| Illiterate | 169 (77.2) | 508 (70.8) | 2.33 (0.13) | 110 (57.6) | 355 (51.2) | 2.24 (0.13) |
| Literate | 50 (22.8) | 210 (29.2) | 81 (42.4) | 339 (48.8) | ||
| Primary | 38 (17.3) | 92 (43.8) | 42 (22.0) | 137 (40.4) | ||
| Secondary | 12 (5.5) | 67 (31.9) | 16.95 (<0.0001) | 35 (18.3) | 96 (28.3) | 5.28 (0.008) |
| Junior college | - | 51 (24.3) | 4 (2.1) | 106 (31.3) | ||
| Tobacco habits (smoking/chewing) | ||||||
| No | 93 (42.5) | 434 (60.4) | 67 (35.1) | 320 (46.1) | ||
| Yes | 126 (57.5) | 284 (39.6) | 124 (64.9) | 374 (53.9) | ||
| Chewing | 126 | 218 | 28.32 (<0.0001) | 25 (both) | 364 | 6.97 (0.008) |
| Smoking | 6 (both) | 66 | 124 | 10 | ||
| Areca nut/gutka | ||||||
| No | 166 (75.8) | 693 (96.5) | 91.7 (<0.0001) | 141 (73.8) | 568 (81.8) | 11.94 (0.007) |
| Yes | 53 (24.2) | 25 (3.5) | 59 (26.2) | 126 (18.2) | ||
| Alcohol | ||||||
| No | 179 (81.9) | 652 (90.8) | 12.88 (0.003) | 112 (58.5) | 522 (75.2) | 19.45 (<0.0001) |
| Yes | 40 (18.1) | 66 (9.2) | 79 (41.5) | 172 (24.8) | ||
| Green leafy vegetables/week | ||||||
| No | 45 (20.5) | 05 (0.7) | 16 (8.4) | 6 (0.9) | ||
| Yes | 174 (79.5) | 713 (99.3) | 175 (91.6) | 688 (99.1) | ||
| Once a week | 46 (21.0) | 74 (10.4) | 127.02 (<0.0001) | 36 (18.8) | 50 (7.3) | 31.83 (<0.0001) |
| Twice a week | 76 (34.7) | 367 (51.5) | 72 (37.7) | 376 (54.7) | ||
| Thrice a week | 36 (16.4) | 163 (22.9) | 51 (26.7) | 174 (25.3) | ||
| Four times a week | 16 (7.4) | 109 (15.3) | 16 (8.4) | 88 (12.8) | ||
| Citrus fruit | ||||||
| No | 78 (35.6) | 228 (31.8) | 99 (51.8) | 198 (28.5) | 35.44 (<0.0001) | |
| Yes | 141 (64.4) | 490 (68.2) | 0.97 (0.32) | 92 (48.2) | 496 (71.5) | |
| Protein intake (vegetarian: pulses/milk) | ||||||
| No | 58 (26.5) | 26 (3.6) | 4.01 (0.05) | 84 (44) | 37 (5.3) | 186.28 (<0.0001) |
| Yes | 161 (73.5) | 692 (96.4) | 107 (56) | 657 (94.7) | ||
| Protein intake (nonvegetarian: egg, meat**) | ||||||
| No | 51 (23.3) | 122 (17.0) | 4.01 (<0.05) | 18 (9.4) | 65 (9.4) | 0.0006 (0.98) |
| Yes** | 168 (76.7) | 596 (83.0) | 173 (90.6) | 629 (90.6) |
*BPL: Below poverty line, **Nonveg was taken once or twice a week only
Comparative status of the overall laboratory parameters in both sexes
| Sex | Age groups (no participants) | Mean±SD | |||||||
|---|---|---|---|---|---|---|---|---|---|
| Age (years) | Height (cm) | Weight (kg) | BMI | SBP (mmHg) | DBP (mmHg) | CBG* (mg/dl) | Cholesterol* (mg/dl) | ||
| Females | 18-39 (598) | 27.5±5.88 | 150.1±6.88 | 43.1±7.16 | 19.1±3.16 | 114.8±13.91 | 71.6±10.61 | 93.4±6.49 (456) | 133.5±34.99 (320) |
| 40-59 (238) | 47.6±5.65 | 149.1±6.23 | 43.2±8.30 | 19.8±3.53 | 124.1±16.71 | 75.9±9.73 | 98.5±4.91 (139) | 158.5±35.50 (93) | |
| >60 (124) | 65.7±5.83 | 148.1±7.72 | 42.0±8.42 | 19.02±3.32 | 133.5±22.29 | 77.3±10.83 | 99.5±5.59 (75) | 161.51±36.12 (49) | |
| Total (960) | 37.2±14.89 | 149.7±6.82 | 43.1±7.56 | 19.1±3.34 | 119.4±10.65 | 73.3±10.65 | 95.4±14.44 (670) | 141.5±37.14 (462) | |
| Males | 18-39 (569) | 27.5±6.02 | 160.7±7.55 | 51.2±8.76 | 19.8±3.07 | 123.4±13.48 | 74.4±10.30 | 95.4±15.84 (410) | 131.9±36.24 (280) |
| 40-59 (225) | 46.7±5.68 | 160.0±7.25 | 53.5±9.72 | 20.9±3.57 | 126.2±18.46 | 79.8±17.08 | 109.8±51.15 (105) | 131.5±35.85 (76) | |
| >60 (110) | 67.1±6.88 | 159.0±6.92 | 49.5±10.1 | 19.5±3.44 | 129.2±20.88 | 75.0±12.4 | 105.2±38.26 (53) | 153.0±36.46 (36) | |
| Total (904) | 37.1±15.04 | 160.3±7.41 | 51.5±9.25 | 20.0±3.28 | 124.8±15.99 | 75.9±12.75 | 102.8±28.91 (568) | 137.6±37.21 (392) | |
| Overall females versus males | 0.1442 | 32.159 | 21.521 | 5.865 | 8.627 | 4.786 | 5.830 | 1.763 | |
| <0.89 (NS) | <0.0001 | <0.0001 | <0.0001 | <0.0001 | <0.0001 | <0.0001 | <0.08 (NS) | ||
NS: Not significant, BMI: Body mass index, CBG: Capillary blood glucose, SBP: Systolic blood pressure, DBP: Diastolic blood pressure, SD: Standard deviation, *Figures in parentheses denote the number of the participants in the group
Tribe-specific anthropometric information, blood pressure, capillary blood glucose, and cholesterol in females
| Age group | Participants no. | Results (mean±SD) | ||||||
|---|---|---|---|---|---|---|---|---|
| Height (cm) | Weight (kg) | BMI | SBP (mmHg) | DBP (mmHg) | CBG* (mg/dl) | Cholesterol* (mg/dl) | ||
| 18-39 | BH (211) | 150.7±6.92 | 44.1±7.51 | 19.4±3.00 | 112.9±12.16 | 70.3±9.61 | 84.7±15.88 (107) | 155.5±32.21 (14) |
| KA (207) | 149.5±7.77 | 42.3±7.02 | 19.0±3487 | 119.0±15.63 | 75.1±11.63 | 95.6±13.07 (195) | 130.5±37.09 (173) | |
| KO (114) | 149.0±5.34 | 43.4±6.49 | 19.3±2.95 | 113.4±13.4 | 71.0±10.28 | 94.6±12.80 (58) | 137.8±31.24 (78) | |
| TH (66) | 150.9±6.07 | 42.8±7.27 | 18.9±3.41 | 110.3±11.80 | 65.8±6.53 | 93.8±11.85 | 128.2±32.74 (35) | |
| 40-59 | BH (85) | 149.3±6.54 | 45.7±8.68 | 20.5±3.77 | 127.1±19.80 | 75.4±8.70 | 90.9±14.64 (39) | 160.2±49.52 (6) |
| KA (61) | 149.3±6.48 | 41.5±7.60 | 18.6±3.35 | 126.8±19.83 | 80.1±10.40 | 106.5±50.95 (58) | 143.8±34.86 (49) | |
| KO (53) | 148.6±6.96 | 45.1±7.66 | 20.4±2.95 | 126.9±20.32 | 76.1±10.46 | 95.8±8.90 (33) | 168.8±32.21 (38) | |
| TH (39) | 149.1±3.85 | 44.1±8.63 | 19.8±3.61 | 121.2±13.72 | 70.4±8.39 | 98.5±15.94 (39) | 152.2±31.73 (20) | |
| ≥60 | BH (64) | 149.8±7.37 | 45.7±8.68 | 20.5±3.77 | 121.8±13.09 | 73.8±8.56 | 88.6±14.15 (25) | 148.2±21.32 (5) |
| KA (29) | 146.6±6.10 | 40.2±7.27 | 18.7±3.32 | 145.2±23.97 | 85.8±11.05 | 101.8±14.12 (29) | 147.2±31.19 (23) | |
| KO (24) | 145.4±9.78 | 40.7±8.96 | 19.2±3.72 | 139.1±20.09 | 78.5±10.63 | 112.9±42.92 (15) | 183.4±34.27 (15) | |
| TH (7) | 149.3±6.59 | 42.4±6.02 | 19.0±2.09 | 125.8±21.68 | 70.4±9.71 | 99.5±13.3 (7) | 172.5±43.67 (6) | |
| Total | BH (360) | 150.2±6.93 | 44.3±8.66 | 19.6±3.29 | 117±15.10 | 72.1±9.46 | 86.7±15.51 (171) | 155.1±34.20 (25) |
| KA (297) | 149.2±7.39 | 41.9±7.26 | 18.9±3.43 | 123.1±18.99 | 77.2±11.82 | 98.5±26.41 (282) | 134.7±36.6 (245) | |
| KO (191) | 149.0±6.63 | 43.5±7.25 | 19.6±2.91 | 120.4±18.65 | 73.4±10.73 | 97.6±21.4 (106) | 152.0±36.27 (131) | |
| TH (112) | 150.2±5.46 | 43.3±7.68 | 19.2±3.42 | 115.1±14.34 | 67.7±7.02 | 95.8±13.59 (112) | 140.4±36.34 (61) | |
*Figures in parentheses denote the number of participants in the group. One-way ANOVA - 18-39: Height F=2.27, P=0.079 (NS), weight F=2.32, P=0.074 (NS), BMI F=0.77, P=0.513 (NS), SBP F=10.68, P=0.001 (BH vs. KA P=0.001, KA vs. TH P=0.001, KA vs. TH P=0.001), DBP F=16.47, P=0.001 (BH vs. KA P=0.001, BA vs. TH P=0.01, KA vs. TH P=0.01), CBG F=15.71, P=0.001 (BH vs. KA P=0.001, BH vs. KO P=0.001, BH vs. TH P=0.001), cholesterol F=2.93 P=0.034 (however there were no inter tribal differences). 40–59: Height F=0.161, P=0.92 (NS), weight F=3.38, P=0.019 (BH vs. KA P=0.05), BMI F=4.08, P=0.008 (BH vs. KA P=0.01, KA vs. KO P=0.05), SBP F=0.99, P=0.397, DBP F=8.38, P=0.001 (BH vs. KA P=0.5, BH vs. KO P=0.05, KA vs. TH P=0.01, KO vs. TH P=0.05), CBG F=2.026 P=0.11 (NS), cholesterol F=3.88, P=0.01 (however there were no inter-tribal difference). ≥60: Height F=2.51, P=0.06 (NS), weight F=3.93, P=0.01 (BH vs. KA P=0.05), BMI F=2.05, P=0.11, SBP F=13.36, P<0.001 (BH vs. KN P=0.001, BH vs. KO P=0.001), DBP F=11.597, P=0.001 (BH vs. KA P=0.01, KA vs. KO P=0.05, KA vs. TH P=0.01), CBG F=3.75, P=0.015 (BH vs. KO P=0.01), cholesterol F=4.12 P=0.115 (KA vs. TH P=0.05). Overall: Height F=2.01, P=0.11 (NS), weight F=5.12 P=0.016 (BH vs. KA P=0.01), BMI F=3.01, P=0.023 (BH vs. KA P=0.05), SBP F=9.64, P=0.001 (BH vs. KA P=0.001, KA vs. TH P=0.001, KO vs. TH P=0.05), DBP F=26.98, P=0.001 (BH vs. KA P=0.001, BH vs. TH P=0.001, KA vs. KO P=0.001, KA vs. TH P<0.001, KO vs. TH P<0.001), CBG F=11.66, P<0.001 (BH vs. KA P<0.001, BH vs. KO P<0.001, BH vs. TH P<0.01), cholesterol F=7.696, P=0.001 (BH vs. KA P=0.001, KA vs. KO P=0.001). BMI: Body mass index, BH: Bhils, KO: Kokana, KA: Katkaris, TH: Thakars, CBG: Capillary blood glucose, SBP: Systolic blood pressure, DBP: Diastolic blood pressure, SD: Standard deviation, NS: Not significant
Tribe-specific anthropometric information, blood pressure, capillary blood glucose and cholesterol on males
| Age group | Participants no | Results (mean±SD) | ||||||
|---|---|---|---|---|---|---|---|---|
| Height (cm) | Weight (kg) | BMI | SBP (mmHg) | DBP (mmHg) | CBG* (mg/dl) | Cholesterol* (mg/dl) | ||
| 18–39 | BH (243) | 160.3±8.24 | 51.8±9.26 | 19.9±3.23 | 123.2±14.17 | 74.5±10.77 | 86.5±18.60 (96) | 152.7±36.88 (18) |
| KA (180) | 160.4±6.54 | 49.8±8.21 | 19.3±3.10 | 125.1±13.63 | 75.4±10.71 | 97.1±14.66 (162) | 125.1±35.93 (162) | |
| KO (91) | 160.6±6.27 | 50.7±8.27 | 19.6±2.57 | 122.4±11.64 | 73.5±9.13 | 94.3±9.23 (63) | 132.9±30.69 (60) | |
| TH (55) | 162.2±7.35 | 54.6±8.08 | 20.7±2.79 | 120.9±12.22 | 72.9±8.25 | 95.1±10.56 (55) | 148.5±37.14 (55) | |
| 40–59 | BH (88) | 160.3±7.52 | 53.2±10.00 | 20.7±3.84 | 124.8±17.73 | 80.7±22.0 | 94.7±16.22 (33) | 156.5±26.21 (4) |
| KA (64) | 158.8±7.64 | 52.0±8.79 | 20.6±3.29 | 131.5±23.36 | 83.6±13.55 | 117.0±57.68 (55) | 137.8±36.17 (44) | |
| KO (47) | 160.1±6.34 | 55.2±10.27 | 21.5±3.42 | 124.0±13.00 | 77.5±9.31 | 117.2±54.69 (27) | 165.7±32.06 (34) | |
| TH (26) | 161.2±6.86 | 54.6±9.67 | 21.0±3.63 | 122.0±12.88 | 72.3±8.70 | 100.6±17.57 (26) | 154.7±35.18 (12) | |
| ≥60 | BH (57) | 158.7±7.46 | 51.0±11.53 | 20.1±3.67 | 128.1±22.28 | 75.5±12.84 | 88.9±19.37 (16) | 187.8±47.62 (5) |
| KA (19) | 160.8±6.73 | 47.9±9.69 | 18.5±3.70 | 134.2±25.31 | 77.5±14.38 | 112.5±37.21 (14) | 120.5±20.99 (9) | |
| KO (23) | 158.4±6.72 | 47.8±7.72 | 19.1±2.85 | 128.5±16.57 | 72.4±11.72 | 122.2±61.28 (12) | 162.1±20.37 (16) | |
| TH (11) | 158.5±4.45 | 48.0±6.30 | 19.1±2.66 | 128.5±11.02 | 74.2±6.13 | 109.9±15.66 (11) | 148.3±46.19 (6) | |
| Overall | BH (388) | 160.3±8.24 | 51.8±9.80 | 20.1±3.45 | 124.3±16.46 | 76.1±14.3 | 88.6±18.37 (145) | 159.8±38.80 (27) |
| KA (263) | 160.0±6.84 | 50.2±8.51 | 19.6±3.23 | 127.3±17.70 | 77.5±12.21 | 102.8±32.96 (231) | 127.5±35.76 (215) | |
| KO (161) | 160.1±6.36 | 51.6±9.13 | 20.1±3.01 | 123.7±12.92 | 74.4±9.72 | 103.4±37.09 (102) | 147.3±33.61 (110) | |
| TH (92) | 161.5±6.98 | 53.8±8.63 | 20.6±3.06 | 122.1±12.39 | 72.9±8.10 | 97.4±13.61 (92) | 150.3±37.06 (40) | |
*Figures in parentheses denote the number of participants in the group. One-way ANOVA - 18-39: height F=1.04, P=0.37 (NS), weight F=2.74, P=0.06, BMI F=1.97 P=0.14 (NS), SBP F=1.97 P=0.14, DBP F=1.034 P=0.35 (NS), CBG F=14.95, P=0.001 (BH vs. KA, P=0.001; BH vs. KO, P=0.01; KA vs. KO, P=0.05), cholesterol F=5.63, P=0.004 (BH vs. KA, P<0.01; BH vs. KO, P=0.05, KA vs. KO, P=0.05). 40-59: height F=0.84, P=1.00 (NS), weight F=1.483 P=0.23 (NS), BMI F=0.68, P=0.56 (NS), SBP F=2.03 P=0.11 (NS), DBP F=3.35 P<0.02 (KA vs. TH, P=0.05); CBG F=3.35 P=0.08 (NS), cholesterol F=4.34, P=0.007 (KA vs. KO, P<0.01) (≥60): height F=0.54, P=0.66 (NS), weight F=0.87, P=0.46 (NS), BMI F=1.27, P=0.29 (NS), SBP F=0.39, P=0.75 (NS), DBP F=0.64, P=0.59 (NS) CBG F=2.07< P = 0.12 (NS), cholesterol F=6.12, P=0.002 (BH vs. KA, P=0.01; KA vs. KO, P=0.05). Overall: height F=0.99, P=0.39 (NS), weight F=3.81 P=0.01 (KA vs. TH, P=0.01), BMI F=2.51 P=0.58, SBP F=3.43, P=0.017 (KA vs. KO, P=0.05), DBP F=4.05, P=0.007 (KA vs. KH, P=0.05), CBG F=8.74, P=0.001 (BH vs. KA, P=0.001, BH vs. KO, P=0.001, KA vs. TH, P<0.01), cholesterol F=13.75, P=0.001 (BH vs. KA, P<0.001; KA vs. KO, P=0.001, KA vs. TH, P=0.01). BMI: Body mass index, BH: Bhils, KO: Kokana, KA: Katkaris, TH: Thakars, CBG: Capillary blood glucose, SBP: Systolic blood pressure, DBP: Diastolic blood pressure, SD: Standard deviation, NS: Not significant
Prevalence of noncommunicable disorders in females
| STs | Age group (years) | Total number | No participants | Hypercholesterolemia | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| BMI (kg/m2) | SBP (mmHg) | CBG (mg/dl) | ||||||||||||
| UW <18.5 | No 18.5-24.9 | Over weight ≥25 | OB ≥30 | Normal <120 | Pre-HTN 12-139 | HTN ≥140 | Total | Normal <110 | IFG 111-125 | Diabetes ≥126 | ||||
| BH | <40 | 211 | 85 | 119 | 10 | 3 | 163 | 46 | 2 | 107 | 102 | 1 | 4 | 1/14 |
| 40-59 | 85 | 31 | 41 | 13 | - | 40 | 35 | 10 | 39 | 35 | 3 | 1 | 1/6 | |
| ≥60 | 64 | 32 | 28 | 4 | - | 23 | 29 | 12 | 25 | 23 | 1 | 1 | 0/5 | |
| All ages | 360 | 148 (41.1) | 188 (52.2) | 24 (6.7) | 3 (0.8) | 226 (62.8) | 110 (30.5) | 24 (6.7) | 171 | 160 (93.6) | 5 (2.9) | 6 (3.5) | 2/25 (4) | |
| KA | <40 | 207 | 100 | 93 | 14 | 2 | 121 | 69 | 17 | 195 | 178 | 11 | 6 | 7/170 |
| 40-59 | 61 | 33 | 25 | 3 | - | 23 | 27 | 11 | 58 | 50 | 3 | 5 | 2/49 | |
| ≥60 | 29 | 18 | 10 | 1 | 1 | 3 | 11 | 15 | 28 | 22 | 5 | 1 | 1/23 | |
| All ages | 297 | 151 (50.8) | 128 (43.1) | 18 (6.1) | 3 (1.0) | 147 (49.5) | 107 (36) | 43 (14.5) | 281 | 250 (89.0) | 19 (6.8) | 12 (4.3) | 10/242 (4.1) | |
| KO | <40 | 114 | 48 | 62 | 4 | - | 85 | 23 | 6 | 58 | 54 | 3 | 1 | 3/77 |
| 40-59 | 53 | 16 | 35 | 2 | 1 | 23 | 19 | 11 | 33 | 30 | 3 | Nil | 7/38 | |
| ≥60 | 24 | 11 | 11 | 2 | - | 4 | 12 | 8 | 15 | 10 | 2 | 3 | 6/15 | |
| All ages | 191 | 75 (39.3) | 108 (65.5) | 8 (4.2) | 1 (0.5) | 112 (58.6) | 54 (28.3) | 25 (13.1) | 106 | 94 (88.7) | 8 (7.5) | 4 (3.8) | 16/130 (12.3) | |
| TH | <40 | 66 | 37 | 27 | 2 | 1 | 56 | 9 | 1 | 66 | 61 | 4 | 1 | 1/35 |
| 40-59 | 39 | 15 | 21 | 3 | 1 | 20 | 13 | 6 | 39 | 34 | 2 | 3 | 1/20 | |
| ≥60 | 7 | 3 | 4 | - | - | 4 | 2 | 1 | 7 | 6 | 1 | Nil | 1/6 | |
| All ages | 112 | 55 (49.1) | 52 (46.4) | 5 (4.5) | 2 (1.8) | 80 (71.5) | 24 (21.4) | 8 (7.1) | 112 | 101 (90.1) | 7 (6.3) | 4 (3.6) | 3/61 (4.9) | |
| Total | <40 | 598 | 270 | 301 | 33 | 6 | 425 | 147 | 26 | 457 | 422 | 20 | 15 | 12/300 |
| 40-59 | 238 | 95 | 122 | 21 | 2 | 106 | 94 | 38 | 139 | 124 | 10 | 5 | 11/113 | |
| ≥60 | 124 | 64 | 53 | 1 | 1 | 34 | 54 | 36 | 75 | 61 | 9 | 5 | 8/49 | |
| All ages | 960 | 429 (44.7) | 476 (49.6) | 55 (5.7) | 9 (0.9) | 565 (58.9) | 295 (30.7) | 100 (10.4) | 671 | 607 (90.5) | 39 (5.8) | 25 (3.7) | 31/462 (6.7) | |
| Females and males | All ages | 1864 | 759 (40.7) | 969 (52.0) | 119 (6.4) | 17 (0.9) | 923 (49.5) | 723 (38.8) | 218 (11.7) | 1241 | 1096 (88.3) | 83 (6.7) | 62 (5) | 6.6 (56/854) |
χ2 for trend: Age versus (a) OB 5.36; P=0.02 (b) HTN 77.42, P <0.001; (c) diabetes 1.23; <0.267; (d) hypercholesterolemia 12.39, P <0.001, BMI versus (a) HTN 7.89, <0.005; diabetes 4.25, <0.04; (c) hypercholesterolemia 4.05, P=0.04. UW: Underweight, OB: Obese, HTN: Hypertension, IFG: Impaired fasting glucose, BH: Bhils, KO: Kokana, KA: Katkaris, TH: Thakars, STs: Scheduled tribes, BMI: Body mass index, SBP: Systolic blood pressure, CBG: Capillary blood glucose
Prevalence of noncommunicable disorders in males
| STs | Age group (years) | Total number | Number in each category | Hypercholesterolemia (mg/dl) | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| BMI (kg/m2) | SBP (mmHg) | CBG (mg/dl) | ||||||||||||
| UW <18.5 | 18.5-24.9 | Over weight ≥25 | OB ≥30 | Normal <120 | Pre-HTN 12-139 | HTN ≥140 | Total number | Normal <110 | IFG 111-125 | Diabetes ≥126 | ||||
| BH | <40 | 243 | 94 | 124 | 25 | 1 | 96 | 127 | 20 | 96 | 87 | 6 | 3 | 1/18 |
| 40-59 | 88 | 26 | 49 | 13 | 2 | 41 | 33 | 14 | 33 | 29 | 3 | 1 | 0/4 | |
| ≥60 | 57 | 22 | 28 | 7 | 1 | 22 | 23 | 12 | 16 | 15 | - | 1 | 2/5 | |
| All ages | 388 | 142 (36.6) | 201 (51.8) | 45 (11.6) | 4 (1.0) | 159 (40.9) | 183 (47.2) | 46 (11.9) | 145 | 131 (90.3) | 9 (6.2) | 5 (3.5) | 3/27 (11.1) | |
| KA | <40 | 180 | 79 | 89 | 12 | 2 | 60 | 103 | 17 | 162 | 139 | 15 | 8 | 24/165 |
| 40-59 | 64 | 18 | 40 | 6 | 1 | 20 | 26 | 18 | 55 | 40 | 5 | 10 | 2/44 | |
| ≥60 | 19 | 10 | 7 | 2 | - | 6 | 6 | 7 | 14 | 10 | 1 | 3 | 0/9 | |
| All ages | 263 | 107 (45.3) | 136 (57.1) | 20 (7.6) | 3 (1.1) | 86 (32.7) | 135 (51.3) | 42 (16) | 231 | 189 (81.8) | 21 (9.1) | 21 (9.1) | 6/218 (2.8) | |
| KO | <40 | 91 | 37 | 51 | 3 | - | 45 | 39 | 7 | 63 | 60 | 3 | - | 2/61 |
| 40-59 | 47 | 10 | 31 | 7 | 1 | 22 | 17 | 8 | 27 | 17 | 4 | 6 | 15/34 | |
| ≥60 | 23 | 10 | 13 | - | - | 8 | 8 | 7 | 12 | 10 | - | 2 | 1/16 | |
| All ages | 161 | 57 (35.4) | 94 (58.4) | 10 (6.2) | 1 (0.6) | 75 (46.6) | 64 (38.8) | 22 (13.7) | 102 | 87 (85.3) | 7 (6.7) | 8 (7.8) | 8/111 (7.2) | |
| TH | <40 | 55 | 13 | 439 | 3 | - | 26 | 25 | 4 | 55 | 51 | 3 | 1 | 13/22 |
| 40-59 | 26 | 6 | 16 | 4 | - | 9 | 14 | 3 | 26 | 21 | 4 | 1 | 1/12 | |
| ≥60 | 11 | 5 | 6 | - | - | 3 | 7 | 1 | 11 | 10 | - | 1 | 1/6 | |
| All ages | 92 | 23 (25) | 61 (66.4) | 7 (7.6) | 38 (41.3) | 46 (50) | 8 (8.7) | 92 | 82 (89.1) | 7 (7.6) | 3 (3.3) | 5/40 (12.5) | ||
| Total | <40 | 569 | 223 | 303 | 43 | 3 | 227 | 294 | 48 | 376 | 337 | 27 | 12 | 10/262 |
| 40-59 | 225 | 60 | 136 | 29 | 4 | 92 | 90 | 43 | 141 | 107 | 16 | 18 | 8/94 | |
| ≥60 | 110 | 47 | 54 | 9 | 1 | 39 | 44 | 27 | 53 | 45 | 1 | 7 | 4/36 | |
| All ages | 904 | 330 (36.5) | 493 (54.5) | 81 (9) | 8 (0.9) | 358 (39.6) | 428 (47.3) | 118 (13.1) | 570 | 489 (85.8) | 44 (9.0) | 37 (6.5) | 22/392 (5.6) | |
| Females and males | All ages | 1864 | 759 (40.7) | 969 (52.0) | 119 (6.4) | 17 (0.9) | 923 (49.5) | 723 (38.8) | 218 (11.7) | 1241 | 1096 (88.3) | 83 (6.7) | 62 (5) | 6.6 (56/854) |
χ2 for trend: Age versus (a) OB 5.00; P=0.03; (b) HTN 29.92; P <0.001; (c) diabetes 9.23; P <0.002; (d) hypercholesterolemia 5.03, P=0.02; BMI versus (a) HTN 39.4, P <0.001; (b) diabetes 7.74, P <0.01; (c) hypercholesterolemia 2.85; P=0.09. UW: Underweight, OB: Obese, HTN: Hypertension, IFG: Impaired fasting glucose, KA: Katkaris, BH: Bhils, KO: Kokana, TH: Thakars, SBP: Systemic blood pressure, CBG: Capillary blood glucose, STs: Scheduled tribes, BMI: Body mass index
Interrelationship of noncommunicable disorder and the risk factors – statistical analysis
| Risk factors | Gender | Parameters | No. of participants | |||
|---|---|---|---|---|---|---|
| Total | Normal | Affected (percentage in parentheses) | ||||
| Overweight versus HTN | Female | BMI <25 | 905 | 824 | 81 (9.0) | 14.04 (<0.001***) |
| BMI >25 | 55 | 41 | 14 (25.5) | |||
| BMI <23 | 852 | 776 | 76 (8.9) | 19.13 (0.001***) | ||
| BMI >23 | 108 | 83 | 25 (23.1) | |||
| Male | BMI <25 | 823 | 740 | 83 (10.1) | 31.65 (0.001***) | |
| BMI >25 | 81 | 55 | 26 (32.1) | |||
| BMI <23 | 738 | 673 | 65 (8.8) | 61.81 (<0.001***) | ||
| BMI >23 | 166 | 113 | 53 (31.9) | |||
| Overweight versus diabetes | Female | BMI <25 | 633 | 610 | 23 (3.6) | 0.87 (<0.35 NS) |
| BMI >25 | 37 | 34 | 3 (8.1) | |||
| BMI <23 | 593 | 572 | 21 (3.5) | 0.89 (<0.34 NS) | ||
| BMI >23 | 77 | 72 | 5 (6.5) | |||
| Male | BMI <25 | 520 | 492 | 28 (5.4) | 7.62 (<0.01**) | |
| BMI >25 | 48 | 40 | 8 (16.7) | |||
| BMI <23 | 463 | 440 | 23 (5) | 6.72 (0.034*) | ||
| BMI >23 | 105 | 92 | 13 (12.4) | |||
| Overweight versus hypercholesterolemia | Female | BMI <25 | 433 | 406 | 27 (6.2) | 1.42 (0.23 NS) |
| BMI >25 | 29 | 25 | 4 (13.8) | |||
| BMI <23 | 408 | 385 | 23 (5.6) | 5.03 (0.02*) | ||
| BMI >23 | 54 | 46 | 8 (14.8) | |||
| Male | BMI <25 | 364 | 346 | 18 (4.9) | 3.15 (0.08 NS) | |
| BMI >25 | 28 | 24 | 4 (14.3) | |||
| BMI <23 | 324 | 310 | 14 (4.3) | 4.56 (0.03*) | ||
| BMI >23 | 68 | 60 | 8 (11.) | |||
| Cholesterol versus HTN | Female | <200 | 413 | 366 | 47 (11.4) | 4.69 (0.03*) |
| >200 | 30 | 22 | 8 (26.7) | |||
| Male | <200 | 370 | 329 | 41 (11.1) | 3.74 (0.53 NS) | |
| >200 | 22 | 16 | 6 (27.3) | |||
| Diabetes versus HTN | Female | Nondiabetes | 645 | 582 | 63 (9.8) | 1.53 (0.22 NS) |
| Diabetic | 26 | 21 | 5 (19.2) | |||
| Male | Nondiabetes | 533 | 477 | 56 (10.5) | 3.24 (0.07 NS) | |
| Diabetic | 37 | 29 | 8 (21.6) | |||
| Diabetes versus hypercholesterolemia | Female | Nondiabetic | 362 | 345 | 17 (4.7) | 4.54 (0.03*) |
| Diabetic | 14 | 11 | 3 (21.4) | |||
| Male | Nondiabetic | 297 | 279 | 18 (6.1) | 0.61 (0.44 NS) | |
| Diabetic | 24 | 24 | 0 (0) | |||
BMI: Body mass index, NS: Not significant, HTN: Hypertension, *Significant (P<0.05); **Highly significant (P <0.01) and ***Very highly significant (P <0.001)